Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).

Joyce RM, Regan M, Ottaway J, Umiel T, Tetreault JC, Levine J, McDermott D, Hurley D, Giallombardo N, Smith T, Lamontagne D, Uhl L, Avigan D.

Ann Oncol. 2003;14 Suppl 1:i21-7.

PMID:
12736227
2.

Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells.

Burgess J, Mills B, Griffith M, Mansour V, Weaver CH, Schwartzberg LS, Snyder EL, Krause DS, Yanovich S, Prilutskaya M, Umiel T, Moss TJ.

Cytotherapy. 2001;3(4):285-94.

PMID:
12171717
3.

Micrometastatic tumor detection in patients with head and neck cancer: a preliminary report.

Wirtschafter A, Benninger MS, Moss TJ, Umiel T, Blazoff K, Worsham MJ.

Arch Otolaryngol Head Neck Surg. 2002 Jan;128(1):40-3.

PMID:
11784252
4.

Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.

Joyce RM, Kraser CN, Tetrealt JC, Giallombardo N, McDermott D, Levine J, Umiel T, Regan M, Hurley D, Uhl L, Avigan D.

Eur J Haematol Suppl. 2001 Jul;64:56-62.

PMID:
11486404
5.

Breast tumor contamination of peripheral blood stem cell harvests: increased sensitivity of detection using immunomagnetic enrichment.

Umiel T, Prilutskaya M, Nguyen NH, Moss TJ, Schaeffer A, Burgess J, Griffith M, Mills B.

J Hematother Stem Cell Res. 2000 Dec;9(6):895-904.

PMID:
11177603
6.

Potent tumoricidal effects of a human cytotoxic T-cell line (TALL-104) against prostate cancer.

Umiel T, Campbell M, Cho S, Deem R, Cesano A, Santoli D, Koeffler H.

Int J Oncol. 1997 Jun;10(6):1125-31.

PMID:
21533494
7.
8.
9.

Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.

Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.

Cancer Res. 1996 Aug 1;56(15):3570-6.

10.

20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

Elstner E, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP.

Cancer Res. 1995 Jul 1;55(13):2822-30.

11.

Transient erythroblastopenia of childhood. Evidence for cell-mediated suppression of erythropoiesis.

Tamary H, Kaplinsky C, Shvartzmayer S, Umiel T, Pecht M, Levin S, Zaizov R.

Am J Pediatr Hematol Oncol. 1993 Nov;15(4):386-91.

PMID:
8214360
12.

Establishment and characterization of a human mixed-lineage, T-lymphoid/myeloid cell line (USP-91).

Umiel T, Rettenmier CW, Siegel S, Ota S, Shimada H, Tran TW, Pattengale PK.

Blood. 1993 Sep 15;82(6):1829-37.

PMID:
8400235
13.
14.

Aminopeptidase P and dipeptidyl peptidase IV activity in human leukocytes and in stimulated lymphocytes.

Hendriks D, De Meester I, Umiel T, Vanhoof G, van Sande M, Scharpé S, Yaron A.

Clin Chim Acta. 1991 Feb 15;196(2-3):87-96.

PMID:
1674239
15.

Recombinant interleukin-2-activated intracavitary lymphocytes: phenotypic characteristics and effector function.

Umiel T, Monselise J, Klein T, Rakovsky E, Fenig E, Lurie H, Adler A.

J Biol Response Mod. 1989 Aug;8(4):409-21.

PMID:
2787838
16.

Biologic and cytogenetic characteristics of leukemia in infants.

Stark B, Vogel R, Cohen IJ, Umiel T, Mammon Z, Rechavi G, Kaplinsky C, Potaznik D, Dvir A, Yaniv Y, et al.

Cancer. 1989 Jan 1;63(1):117-25.

PMID:
2910409
17.

Heterogeneity of childhood acute lymphoblastic leukemia (ALL): monoclonal antibodies phenotyping and induction of differentiation in vitro.

Umiel T, Luria D, Stark B, Cohen IJ, Gozes Y, Kobiler D, Kodman Y, Grunspan A, Dvir A, Yaniv I, et al.

Leukemia. 1988 Dec;2(12 Suppl):88S-96S.

PMID:
3264367
18.

More than two immunoglobulin heavy chain J region genes in the majority of infant leukemia.

Rechavi G, Brok-Simoni F, Katzir N, Mandel M, Umiel T, Stark B, Zaizov R, Ben-Bassat I, Ramot B.

Leukemia. 1988 Jun;2(6):347-50.

PMID:
3131595
19.

Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis.

Stark B, Cohen IJ, Pecht M, Umiel T, Apte RN, Friedman E, Levin S, Vogel R, Schlesinger M, Zaizov R.

Cancer. 1987 Dec 1;60(11):2629-36.

PMID:
2445462
20.

[Autoimmune thrombocytopenic purpura preceding Hodgkin lymphoma].

Goshen Y, Kalinsky H, Umiel T, Pecht M, Zaizov R.

Harefuah. 1987 Nov 1;113(9):209-12. Hebrew. No abstract available.

PMID:
2448195
21.

Undifferentiated leukemia of infancy with t(11:17) chromosomal rearrangement. Coexpressing myeloid and B cell restricted antigens.

Umiel T, Nadler LM, Cohen IJ, Levine H, Stark B, Mammon Z, Dzaldetti M, Rechavi G, Simoni F, Katzir N, et al.

Cancer. 1987 Mar 15;59(6):1143-9.

PMID:
3102033
22.

Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development.

Orgad S, Malone G, Zaizov R, Marinowitz U, McLane MF, Umiel T, Cohen IJ, Vogel R, Cohen-Avishai O, Ramot B, et al.

AIDS Res Hum Retroviruses. 1987 Fall;3(3):323-32.

PMID:
3124874
23.

Leukemia of early infancy. Early B-cell lineage associated with t(4:11).

Stark B, Umiel T, Mammon Z, Galili N, Dzaledetti M, Cohen IJ, Steinberg M, Vogel R, Zaizov R.

Cancer. 1986 Sep 15;58(6):1265-71.

PMID:
3488803
24.
25.

Acute leukemia with mixed lymphoid and myeloid phenotype.

Umiel T, Nadler LM, Levine H, Cohen IJ, Stark B, Zaizov R.

Br J Haematol. 1986 Jan;62(1):196-7. No abstract available.

PMID:
3942694
26.

Long-term culture of infant leukemia cells: dependence upon stromal cells from the bone marrow and bilineage differentiation.

Umiel T, Friedman S, Zaizov R, Cohen IJ, Gozes Y, Epstein N, Kobiler D, Zipori D.

Leuk Res. 1986;10(8):1007-13.

PMID:
3528680
27.

A mouse ear reaction for assessment of human lymphocyte immunocompetence.

Mukamel E, Umiel T, Shohat B, Pecht M, Servadio C, Trainin N.

Immunobiology. 1985 Feb;169(1):21-9.

PMID:
3886530
28.

Lymphoid cells and granulocyte progenitors in early human fetal livers: immunological parameters and in vitro cellular interactions.

Barak Y, Karov Y, Barash A, Umiel T, Rosenberg M, Netzer L, Lancet M, Levin S.

Isr J Med Sci. 1985 Jan;21(1):12-7.

PMID:
3156101
29.

THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.

Umiel T, Pecht M, Trainin N.

J Biol Response Mod. 1984 Aug;3(4):423-34.

PMID:
6332883
30.

Impaired immune regulation in children and adolescents with hemophilia and thalassemia in Israel.

Umiel T, Friedman E, Luria D, Cohen IJ, Kaplinsky H, Netzer L, Pecht M, Trainin N, Zaizov R.

Am J Pediatr Hematol Oncol. 1984 Winter;6(4):371-8.

PMID:
6241995
31.

Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies.

Rosenthal P, Rimm IJ, Umiel T, Griffin JD, Osathanondh R, Schlossman SF, Nadler LM.

J Immunol. 1983 Jul;131(1):232-7.

PMID:
6306100
32.

T cell progenitors in the mouse fetal liver.

Rabinowich H, Umiel T, Globerson A.

Transplantation. 1983 Jan;35(1):40-8.

PMID:
6337435
33.

Acquisition of immune competence by a subset of human cortical thymocytes expressing mature T cell antigens.

Umiel T, Daley JF, Bhan AK, Levey RH, Schlossman SF, Reinherz EL.

J Immunol. 1982 Sep;129(3):1054-60.

PMID:
6980916
35.

Selective decline in differentiating capacity of immunohemopoietic stem cells with aging.

Gozes Y, Umiel T, Trainin N.

Mech Ageing Dev. 1982 Mar;18(3):251-9.

PMID:
6211580
36.

Frequency and restriction of cytotoxic T lymphocyte precursors in neonatally thymectomized mice.

Carnaud C, Umiel T, Gastinel L.

Adv Exp Med Biol. 1982;149:289-95. No abstract available.

PMID:
6983217
38.

Characterization of embryonic liver suppressor cells by peanut agglutinin.

Rabinovich H, Umiel T, Reisner Y, Sharon N, Globerson A.

Cell Immunol. 1979 Oct;47(2):347-55. No abstract available.

PMID:
158436
39.

Suppression of GVH mortality by mouse neonatal liver cells.

Umiel T, Globerson A.

Transplant Proc. 1979 Jun;11(2):1497. No abstract available.

PMID:
38544
40.

Characterization of reactive and suppressive cells in the mouse embryonic liver by peanut agglutinin (PNA).

Globerson A, Rabinowich H, Umiel T, Reisner Y, Sharon N.

Adv Exp Med Biol. 1979;114:345-50.

PMID:
157055
42.

Syngeneic GvH induced in popliteal lymph nodes by spleen cells of old C57BL/6 mice.

Gozes Y, Umiel T, Meshorer A, Trainin N.

J Immunol. 1978 Dec;121(6):2199-204.

PMID:
31401
43.

Inhibition or acceleration of tumor growth by subpopulations of thymus cells separable by a peanut lectin.

Umiel T, Linker-Israeli M, Itzchaki M, Trainin N, Reisner Y, Sharon N.

Cell Immunol. 1978 Apr;37(1):134-41. No abstract available.

PMID:
306880
44.

Development of immunosuppressor cells. Exertion of specific suppression by neonatal liver cells.

Umiel T, Globerson A, Trainin N.

Transplantation. 1977 Oct;24(4):282-9. No abstract available.

PMID:
21476
45.

The role of the thymus in the establishment of suppressor cells in liver chimeras.

Umiel T, Trainin N.

Cell Immunol. 1976 May;23(2):232-9. No abstract available.

PMID:
1277304
46.

Augmentation of cell mediated lysis (CML) by THF.

Umiel T, Altman A, Trainin N.

Adv Exp Med Biol. 1976;66:639-43.

PMID:
1083661
47.
48.

Proceedings: Immunosuppression by embryonic liver cells: a model for establishment of tolerance to self.

Globerson A, Zinkernagel RM, Umiel T.

Isr J Med Sci. 1975 Dec;11(12):1385-6. No abstract available.

PMID:
1218984
49.

Immunosuppression by embryonic liver cells.

Globerson A, Zinkernagel RM, Umiel T.

Transplantation. 1975 Dec;20(6):480-4.

PMID:
128855
50.

Recent studies on the role of the thymus in early stages of lymphopoiesis and immune differentiation.

Trainin N, Zipori D, Umiel T.

Boll Ist Sieroter Milan. 1975 Jul 31;54(3):211-8.

PMID:
766782

Supplemental Content

Support Center